Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: Cancer Sci. 2011 May 9;102(7):1366–1373. doi: 10.1111/j.1349-7006.2011.01931.x

Table 3.

Hematological values for each treatment group in vivo on day 29 (n = 5)

Control (PBS) SeV/ΔF/GFP SeV/ΔF/FIR P-value* P-value**
White blood cells (×104/μL) 9780 ± 3502.4 6020 ± 2730.8 6340 ± 2846.6 0.095 0.861
Hemoglobin (g/dL) 14.30 ± 0.36 14.04 ± 0.23 14.08 ± 0.48 0.217 0.874

Each value represents the median ± SD.

*

SeV/ΔF/GFP (1 × 108 CIU/body) compared with the control.

**

SeV/ΔF/FIR (1 × 108 CIU/body) compared with SeV/ΔF/GFP. CIU, cell-infectious units; SeV/ΔF/FIR, fusion gene deleted non-transmissible Sendai virus vector encoding FUSE-binding protein-interacting repressor; SeV/ΔF/GFP, fusion gene deleted non-transmissible Sendai virus vector encoding green fluorescent protein.